ENHERTU - Discover a new indication & how it may help certain patients with unmet needs ~ March 4th
- Social Media Coordinator
- Feb 17, 2021
- 1 min read
Indication
ENHERTU is a HER2-directed antibody and topoisomerase inhibitor conjugate indicated for the treatment of adult patients with locally advanced or metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma who have received a prior trastuzumab-based regimen.
Comments